Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of CD40 Ligand market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of CD40 Ligandmarket, defines the market attractiveness level of CD40 Ligand market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of CD40 Ligand industry, describes the types of CD40 Ligand market, the applications of major players and the market size, and deeply analyzes the current situation of the global CD40 Ligand market and the development prospects and opportunities of CD40 Ligand industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global CD40 Ligand market in Chapter 13.
By Player:
Juno Therapeutics Inc
Biogen, Inc
Bristol-Myers Squibb Company
Targovax AS
XL-protein GmbH
ImmuNext, Inc
MedImmune, LLC
eTheRNA Immunotherapies NV
By Type:
ISF-35
LOAd-700
MEDI-4920
MegaCD40L
Others
By End-User:
Hepatitis B
Bladder Cancer
Liver Cancer
Ovarian Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 CD40 Ligand Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 CD40 Ligand Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 CD40 Ligand Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 CD40 Ligand Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise CD40 Ligand Market Analysis and Outlook to 2022
-
7.1 Global CD40 Ligand Consumption (2017-2022)
-
7.2 United States CD40 Ligand Consumption (2017-2022)
-
7.3 Europe CD40 Ligand Consumption (2017-2022)
-
7.4 China CD40 Ligand Consumption (2017-2022)
-
7.5 Japan CD40 Ligand Consumption (2017-2022)
-
7.6 India CD40 Ligand Consumption (2017-2022)
-
7.7 South Korea CD40 Ligand Consumption (2017-2022)
8 Region and Country-wise CD40 Ligand Market Analysis and Outlook to 2028
-
8.1 Global CD40 Ligand Consumption Forecast (2022-2028)
-
8.2 United States CD40 Ligand Consumption Forecast (2022-2028)
-
8.3 Europe CD40 Ligand Consumption Forecast (2022-2028)
-
8.4 China CD40 Ligand Consumption Forecast (2022-2028)
-
8.5 Japan CD40 Ligand Consumption Forecast (2022-2028)
-
8.6 India CD40 Ligand Consumption Forecast (2022-2028)
-
8.7 South Korea CD40 Ligand Consumption Forecast (2022-2028)
9 Global CD40 Ligand Market Outlook by Types and Applications to 2022
-
9.1 Global CD40 Ligand Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ISF-35 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global LOAd-700 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global MEDI-4920 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global MegaCD40L Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global CD40 Ligand Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global CD40 Ligand Market Outlook by Types and Applications to 2028
-
10.1 Global CD40 Ligand Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ISF-35 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global LOAd-700 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global MEDI-4920 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global MegaCD40L Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global CD40 Ligand Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global CD40 Ligand Import and Export Analysis (Top 5 Countries)
-
11.1 Global CD40 Ligand Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global CD40 Ligand Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 CD40 Ligand Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global CD40 Ligand Market Competitive Analysis
-
14.1 Juno Therapeutics Inc
-
14.1.1 Juno Therapeutics Inc Company Details
-
14.1.2 Juno Therapeutics Inc CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Juno Therapeutics Inc CD40 Ligand Product and Service
-
14.2 Biogen, Inc
-
14.2.1 Biogen, Inc Company Details
-
14.2.2 Biogen, Inc CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Biogen, Inc CD40 Ligand Product and Service
-
14.3 Bristol-Myers Squibb Company
-
14.3.1 Bristol-Myers Squibb Company Company Details
-
14.3.2 Bristol-Myers Squibb Company CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Company CD40 Ligand Product and Service
-
14.4 Targovax AS
-
14.4.1 Targovax AS Company Details
-
14.4.2 Targovax AS CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Targovax AS CD40 Ligand Product and Service
-
14.5 XL-protein GmbH
-
14.5.1 XL-protein GmbH Company Details
-
14.5.2 XL-protein GmbH CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 XL-protein GmbH CD40 Ligand Product and Service
-
14.6 ImmuNext, Inc
-
14.6.1 ImmuNext, Inc Company Details
-
14.6.2 ImmuNext, Inc CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ImmuNext, Inc CD40 Ligand Product and Service
-
14.7 MedImmune, LLC
-
14.7.1 MedImmune, LLC Company Details
-
14.7.2 MedImmune, LLC CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 MedImmune, LLC CD40 Ligand Product and Service
-
14.8 eTheRNA Immunotherapies NV
-
14.8.1 eTheRNA Immunotherapies NV Company Details
-
14.8.2 eTheRNA Immunotherapies NV CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 eTheRNA Immunotherapies NV CD40 Ligand Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of CD40 Ligand
-
Figure CD40 Ligand Picture
-
Table Global CD40 Ligand Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CD40 Ligand Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CD40 Ligand Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global CD40 Ligand Consumption by Country (2017-2022)
-
Figure United States CD40 Ligand Consumption and Growth Rate (2017-2022)
-
Table Europe CD40 Ligand Consumption and Growth Rate (2017-2022)
-
Figure China CD40 Ligand Consumption and Growth Rate (2017-2022)
-
Figure Japan CD40 Ligand Consumption and Growth Rate (2017-2022)
-
Figure India CD40 Ligand Consumption and Growth Rate (2017-2022)
-
Figure South Korea CD40 Ligand Consumption and Growth Rate (2017-2022)
-
Figure Global CD40 Ligand Consumption Forecast by Country (2022-2028)
-
Figure United States CD40 Ligand Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe CD40 Ligand Consumption Forecast and Growth Rate (2022-2028)
-
Figure China CD40 Ligand Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan CD40 Ligand Consumption Forecast and Growth Rate (2022-2028)
-
Figure India CD40 Ligand Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea CD40 Ligand Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ISF-35 Consumption and Growth Rate (2017-2022)
-
Figure Global LOAd-700 Consumption and Growth Rate (2017-2022)
-
Figure Global MEDI-4920 Consumption and Growth Rate (2017-2022)
-
Figure Global MegaCD40L Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
Figure Global Bladder Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global ISF-35 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global LOAd-700 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MEDI-4920 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MegaCD40L Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global CD40 Ligand Import by Region (Top 5 Countries) (2017-2028)
-
Table Global CD40 Ligand Export by Region (Top 5 Countries) (2017-2028)
-
Table Juno Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Juno Therapeutics Inc CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics Inc CD40 Ligand Product and Service
-
Table Biogen, Inc (Foundation Year, Company Profile and etc.)
-
Table Biogen, Inc CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen, Inc CD40 Ligand Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company CD40 Ligand Product and Service
-
Table Targovax AS (Foundation Year, Company Profile and etc.)
-
Table Targovax AS CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
Table Targovax AS CD40 Ligand Product and Service
-
Table XL-protein GmbH (Foundation Year, Company Profile and etc.)
-
Table XL-protein GmbH CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
Table XL-protein GmbH CD40 Ligand Product and Service
-
Table ImmuNext, Inc (Foundation Year, Company Profile and etc.)
-
Table ImmuNext, Inc CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmuNext, Inc CD40 Ligand Product and Service
-
Table MedImmune, LLC (Foundation Year, Company Profile and etc.)
-
Table MedImmune, LLC CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedImmune, LLC CD40 Ligand Product and Service
-
Table eTheRNA Immunotherapies NV (Foundation Year, Company Profile and etc.)
-
Table eTheRNA Immunotherapies NV CD40 Ligand Sales, Price, Value and Gross Profit (2017-2022)
-
Table eTheRNA Immunotherapies NV CD40 Ligand Product and Service
-
